Day One Biopharmaceuticals DAWN Q4 2025 Earnings EPS Miss Reflects RD Spend Amid PreRevenue Status Enhabit Inc EHAB Q4 2025 Earnings EPS Narrowly Misses Estimates Stock Edges Higher FIP Q1 2026 Earnings Significant EPS Miss Weighs on Shares BRC Q1 2026 Earnings EPS Beats Estimates by 104 as Stock Rises 35 CYH Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges BWFG Q1 2026 Earnings EPS Surpasses Estimates by 13